Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Late to Retirement Planning? 4 Strategies to Help You Catch Up to Your Peers
Late to Retirement Planning? 4 Strategies to Help You Catch Up to Your Peers

If you're late to retirement planning, beating yourself up about it accomplishes nothing. As someone who's had to start over more than once, I'm here to tell you that it's possible, and the further

Village Farms Sales Jump 12 Percent
Village Farms Sales Jump 12 Percent

Village Farms International (NASDAQ:VFF), a diversified greenhouse grower and international cannabis producer, reported GAAP results for Q2 2025 on August 11, 2025. The company posted GAAP earnings

Kymera Revenue Drops 55 Percent in Q2
Kymera Revenue Drops 55 Percent in Q2

Kymera Therapeutics (NASDAQ:KYMR), a biotechnology company recognized for its targeted protein degradation technology, released its second quarter 2025 results on August 11, 2025. The most notable

Immunovant Posts 34% R&D Jump in Q1Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Immunovant Posts 34% R&D Jump in Q1

Immunovant (NASDAQ:IMVT), a clinical-stage biotechnology company focused on therapies for autoimmune conditions, reported results for the quarter ended June 30, 2025, on August 11, 2025. Net loss

Humacyte Posts Q2 Revenue Miss
Humacyte Posts Q2 Revenue Miss

Humacyte (NASDAQ:HUMA), a regenerative medicine company focused on bioengineered human tissues, released its Q2 FY2025 earnings on August 11, 2025. The most notable news from the release was the

Intermex Posts Mixed Results in Q2
Intermex Posts Mixed Results in Q2

International Money Express (NASDAQ:IMXI), a leading provider of money transfer services primarily between the United States and Latin America, reported results for Q2 2025 on August 11, 2025. The

AMC Posts 36 Percent Revenue Jump in Q2Photo, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
AMC Posts 36 Percent Revenue Jump in Q2

AMC Entertainment (NYSE:AMC), a leading movie theater operator, released its second quarter 2025 earnings on August 11, 2025. The company delivered a strong recovery, reporting GAAP revenue of

Better Artificial Intelligence Stock: ASML vs. AMDPhoto, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
Better Artificial Intelligence Stock: ASML vs. AMD

Artificial intelligence (AI) remains a hot area to invest in, as seen in Nvidia's share price, which is up over 30% this year through Aug. 6. Two AI businesses to consider are ASML Holding (NASDAQ:

Harvard Bioscience Tops Q2 Revenue ViewsPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Harvard Bioscience Tops Q2 Revenue Views

Harvard Bioscience (NASDAQ:HBIO), a provider of specialized laboratory technologies for biomedical and life sciences research, released its financial results for the second quarter of fiscal 2025 on

Compass Therapeutics Posts Wider Q2 Loss
Compass Therapeutics Posts Wider Q2 Loss

Compass Therapeutics (NASDAQ:CMPX), a clinical-stage biotechnology company focused on developing novel bispecific antibody therapies for cancer, released its second quarter results on August 11

1 Reason to Buy Berkshire Hathaway (BRK.A) StockPhoto, wide shot, wide-angle lens, soft focus,  Risk management company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-vkrXsXVXnZepYEkiT4BvjtCA.png?st=2023-05-14T13%3A27%3A43Z&se=2023-05-14T15%3A27%3A43Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T00%3A09%3A01Z&ske=2023-05-15T00%3A09%3A01Z&sks=b&skv=2021-08-06&sig=y1VhH4rrtYGKSVOHO3rBwhpmvE42GCwp7%2BKdLaLI7kA%3D
1 Reason to Buy Berkshire Hathaway (BRK.A) Stock

Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) is one of the world's largest and most successful companies. Led by visionary investor and CEO Warren Buffett since 1965, the investment conglomerate

Excelerate Energy EPS Jumps 31 Percent
Excelerate Energy EPS Jumps 31 Percent

Excelerate Energy (NYSE:EE), a leading provider of Floating Storage and Regasification Units (FSRUs) and integrated LNG solutions, released its earnings for the second quarter of fiscal 2025 on

Owens and Minor Misses Fiscal Q2 Targets
Owens and Minor Misses Fiscal Q2 Targets

Owens & Minor (NYSE:OMI), a leading health care logistics and home health product distribution provider, reported its second quarter 2025 earnings on August 11, 2025. The most notable news was the

1 Reason to Buy EPR Properties (EPR)
1 Reason to Buy EPR Properties (EPR)

EPR Properties (NYSE: EPR) is a real estate investment trust, or REIT, that focuses exclusively on experiential properties. In its portfolio of more than 300 properties are movie theaters, "eat and

The SEC Wants to Supercharge Super-Apps. Here's What Investors Need to Know
The SEC Wants to Supercharge Super-Apps. Here's What Investors Need to Know

Paul Atkins, chairman of the Securities and Exchange Commission (SEC), has unveiled a host of new initiatives under the umbrella of Project Crypto. He says he wants to modernize the SEC's rules and

Is Wolfspeed a Buy?Photo, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
Is Wolfspeed a Buy?

Shares of Wolfspeed (NYSE: WOLF) are down 98% since the company began trading under the WOLF ticker in 2021. The company is working with creditors to restructure its massive debt through the Chapter

Here's How Much a $50-Per-Week Investment in the Nasdaq-100 Could Grow to Be Worth in 10, 20, and 30 YearsPhoto, wide shot, wide-angle lens,  Private equity firm, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/11edc0a6-edfc-46d1-baee-abd4f510abd1.png
Here's How Much a $50-Per-Week Investment in the Nasdaq-100 Could Grow to Be Worth in 10, 20, and 30 Years

The Nasdaq is home to many of the best growth stocks in the world. But an even more exclusive club is the Nasdaq-100 index, which tracks the most valuable stocks on the exchange (excluding financial

RadNet Posts Record Q2 Revenue Up 8%Photo, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
RadNet Posts Record Q2 Revenue Up 8%

RadNet (NASDAQ:RDNT), a major operator of outpatient diagnostic imaging centers, published its second quarter 2025 results on August 11, 2025. The company reported record revenue of $498.2 million

If You'd Invested $1,000 in Progressive Stock (PGR) 10 Years Ago, Here's How Much You'd Have TodayPhoto, wide shot, wide-angle lens, soft focus,  Reinsurance company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-bSRc7PrRT00tZTDNf9SggMTD.png?st=2023-05-06T18%3A48%3A49Z&se=2023-05-06T20%3A48%3A49Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A38%3A49Z&ske=2023-05-07T00%3A38%3A49Z&sks=b&skv=2021-08-06&sig=3seGuy7NQJX9RXUOWr6XArANokWXlKqwnEJxEHfdbSY%3D
If You'd Invested $1,000 in Progressive Stock (PGR) 10 Years Ago, Here's How Much You'd Have Today

Lots of people are probably not interested in how an investment in shares of the Progressive (NYSE: PGR) insurance company has performed over time. They should be, though, because the stock has been

2 Reasons XRP Is the Highest-Upside Cryptocurrency to Buy Right Now
2 Reasons XRP Is the Highest-Upside Cryptocurrency to Buy Right Now

In the period from November 2024 to February 2025, crypto investors saw plenty of evidence of the remarkable upside potential of XRP (CRYPTO: XRP). In just three months, the price of XRP exploded

Rumble Revenue Jumps 12 PercentPhoto, wide shot, wide-angle lens,  Computer hardware manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.theapi.app/temp/32e7a10f-efd0-424a-861f-2f3e0bb7ce02.png
Rumble Revenue Jumps 12 Percent

Rumble (NASDAQ:RUM), a video-sharing and cloud infrastructure company, released its second quarter 2025 results on August 11, 2025. The headline news: GAAP revenue came in at $25.1 million, missing

7 Dividend Stocks to Buy With $2,500 and Hold Forever
7 Dividend Stocks to Buy With $2,500 and Hold Forever

If you're searching for passive income from your investments, dividend stocks can help deliver the goods. Dividend-paying companies share a portion of their profits with shareholders, typically

Are You Falling for These 3 Roth IRA Myths?
Are You Falling for These 3 Roth IRA Myths?

A Roth IRA (Individual Retirement Account) allows you to invest after-tax dollars, meaning you pay taxes on the money before it's invested. The primary advantage is that you don't have to pay taxes

2 Soaring Growth Stocks to Buy and Hold Forever
2 Soaring Growth Stocks to Buy and Hold Forever

Growth stocks are companies generally expected to expand faster than the overall market or their industry peers. These stocks may offer higher potential returns to faithful shareholders in the long

Is Citigroup Stock a Buy Now?Photo, wide shot, wide-angle lens, soft focus,  Asset management firm, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-4Gf80r47YD589EFtjlMy4oXE.png?st=2023-05-06T14%3A52%3A24Z&se=2023-05-06T16%3A52%3A24Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A39%3A24Z&ske=2023-05-07T00%3A39%3A24Z&sks=b&skv=2021-08-06&sig=d8x8qxYEsZ8AfRwcBw8eUkxkNQFVf9GobJgEag27Xug%3D
Is Citigroup Stock a Buy Now?

Citigroup (NYSE: C) did not distinguish itself during the Great Recession. It got caught up in the housing crisis, ending up cutting its dividend and taking a government bailout.

A lot has changed